From: Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial
Patient
UCB1
UCB2
07-06
Semi-identical
02-08
Matched 6/6
4/6 with MM HLA-A
11-10
2/6 with MM HLA-A
12-11
08-12
2/6 with MM HLA-B
12-14